(NYSE: AVNT) Avient's forecast annual revenue growth rate of 4.29% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 3.08%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.23%.
Avient's revenue in 2024 is $3,142,800,000.On average, 6 Wall Street analysts forecast AVNT's revenue for 2024 to be $294,608,446,891, with the lowest AVNT revenue forecast at $292,010,749,318, and the highest AVNT revenue forecast at $298,343,605,932. On average, 6 Wall Street analysts forecast AVNT's revenue for 2025 to be $311,229,699,471, with the lowest AVNT revenue forecast at $308,532,434,129, and the highest AVNT revenue forecast at $315,944,853,371.
In 2026, AVNT is forecast to generate $329,306,902,731 in revenue, with the lowest revenue forecast at $324,051,146,904 and the highest revenue forecast at $334,919,534,245.